发明名称 DIRECTED COMPLEMENTATION
摘要 <p>A method of producing a tumorigenic mouse cell, the tumorigenicity of which depends on a recombinant gene of interest is disclosed. The method involves: (a) providing a conditionally tumorigenic mouse cell containing a recombinant oncogene operably linked to an inducible promoter, wherein (i) expression of the recombinant oncogene is necessary and sufficient for the tumorigenicity of the tumorigenic mouse cell, and (ii) the inducible promoter is in the uninduced state; and (b) introducing into the cell a recombinant gene of interest that functionally complements the oncogene, thereby restoring tumorigenicity without expression of the inducible recombinant oncogene. Also disclosed is a method of testing a compound for anti-tumor effects. The method includes producing tumorigenic mouse cells the tumorigenicity depends on expression of a recombinant gene of interest, implanting the cells in mice and obtaining tumors from the implanted cells, administering test compounds to the mice, and determining anti-tumor effects, if any, of the compounds.</p>
申请公布号 WO2006108123(A1) 申请公布日期 2006.10.12
申请号 WO2006US12965 申请日期 2006.04.05
申请人 AVEO PHARMACEUTICALS, INC.;ROBINSON, MURRAY;O'HAGAN, RONAN;KANNAN, KARUPPIAH;CAI, TI;CHIU, MARIA, ISABEL;LERNER, LORENA;LIN, JIE;ZHOU, YINGHUI 发明人 ROBINSON, MURRAY;O'HAGAN, RONAN;KANNAN, KARUPPIAH;CAI, TI;CHIU, MARIA, ISABEL;LERNER, LORENA;LIN, JIE;ZHOU, YINGHUI
分类号 C12N15/85;A01K67/00;C12N5/10 主分类号 C12N15/85
代理机构 代理人
主权项
地址
您可能感兴趣的专利